Pfizer Inc. (BCBA:PFE)

Market Cap	163.30T
Revenue (ttm)	66.90T
Net Income (ttm)	8.44T
Shares Out	n/a
EPS (ttm)	1,481.43
PE Ratio	19.34
Forward PE	8.48
Dividend	282.72 (3.89%)
Ex-Dividend Date	May 9, 2025

Volume	13,020
Average Volume	13,161
Open	7,370.00
Previous Close	7,280.00
Day's Range	7,230.00 - 7,370.00
52-Week Range	5,990.00 - 10,450.00
Beta	0.49
RSI	56.72
Earnings Date	Aug 5, 2025

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1849
• Employees: 81,000
• Stock Exchange: Buenos Aires Stock Exchange
• Ticker Symbol: PFE

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD